Skip to content

April 2014

The hunt for supersymmetry: Is a choke on the cards?

  • by

As scientists have progressed by leaps and bounds in making discoveries and confirming new ideas, they have been disappointed by how one of their favorite theories has been unable to post a positive status update… 

The nonsense in Wockhardt’s reply to the FDA

  • by

As Sun Pharma buys Ranbaxy for $3.2 billion, let’s not forget that that these companies, and Wockhardt, came under fire last year for maintaining horrible working conditions in their plants.

The Indian medical devices industry stays foreign

  • by

On the one hand, India plans to expand its public healthcare system to more than 500 million people by 2020, and on the other, doesn’t reduce costs of the devices that will form the spine…